Advances have been made in treatment and outcomes for pediatric cancer. However adolescents and young adults (AYAs) with cancer have not experienced similar relative improvements. We undertook a study to develop the methodology necessary for epidemiologic cancer research in these age groups. Our goal was to create the Kids, Adolescents, and Young Adults Cancer (KAYAC) project to create a resource to address research questions relevant to this population. We used a combination of clinic and population-based ascertainment to enroll 111 cases aged 0–39 for this methodology development study. The largest groups of cancer types enrolled include: breast cancer, leukemia, lymphoma, and melanoma. The overall participation rate is 69.8% and varies b...
Adolescent and Young Adult Oncology (AYAO, including patients 15-39 years of age) is an emerging dis...
Background: Low rates of participation of adolescents and young adults (AYAs) in clinical oncology t...
Survival among adolescents and young adults (AYAs) ages 15 to 39 with cancer has not improved to the...
Advances have been made in treatment and outcomes for pediatric cancer. However adolescents and youn...
Brian D Friend,1 Abinav Baweja,2 Gary Schiller,3 Jonathan Bergman,4 Mark S Litwin,4 Jonathan W Goldm...
Background: Cancer is the leading cause of disease-related death among U.S. persons aged 15–39 years...
Worldwide, more than 1.2 million adolescents and young adults (AYAs; those aged 15–39 years) are dia...
Background: The impact of cancer upon children, teenagers and young people can be profound. Research...
Adolescent and young adult (AYA) cancer patients suffer from delay in diagnosis, and lack of central...
Historically, adolescents and young adults (AYA) diagnosed with cancer have been an understudied pop...
Background and AimsAYA (Adolescents and Young Adults) includes 15 to 39 years of age. Over70000 AYAs...
Cancer statistics for adolescents and young adults (AYAs) (aged 15-39 years) are often presented in ...
Simple Summary Adolescents and young adults (AYA), aged 18-39 years at first cancer diagnosis, are r...
Survival for childhood cancers has improved significantly over the last decades. However, patient ou...
OBJECTIVES: To describe the location of treatment, recruitment to clinical trials and outcomes for a...
Adolescent and Young Adult Oncology (AYAO, including patients 15-39 years of age) is an emerging dis...
Background: Low rates of participation of adolescents and young adults (AYAs) in clinical oncology t...
Survival among adolescents and young adults (AYAs) ages 15 to 39 with cancer has not improved to the...
Advances have been made in treatment and outcomes for pediatric cancer. However adolescents and youn...
Brian D Friend,1 Abinav Baweja,2 Gary Schiller,3 Jonathan Bergman,4 Mark S Litwin,4 Jonathan W Goldm...
Background: Cancer is the leading cause of disease-related death among U.S. persons aged 15–39 years...
Worldwide, more than 1.2 million adolescents and young adults (AYAs; those aged 15–39 years) are dia...
Background: The impact of cancer upon children, teenagers and young people can be profound. Research...
Adolescent and young adult (AYA) cancer patients suffer from delay in diagnosis, and lack of central...
Historically, adolescents and young adults (AYA) diagnosed with cancer have been an understudied pop...
Background and AimsAYA (Adolescents and Young Adults) includes 15 to 39 years of age. Over70000 AYAs...
Cancer statistics for adolescents and young adults (AYAs) (aged 15-39 years) are often presented in ...
Simple Summary Adolescents and young adults (AYA), aged 18-39 years at first cancer diagnosis, are r...
Survival for childhood cancers has improved significantly over the last decades. However, patient ou...
OBJECTIVES: To describe the location of treatment, recruitment to clinical trials and outcomes for a...
Adolescent and Young Adult Oncology (AYAO, including patients 15-39 years of age) is an emerging dis...
Background: Low rates of participation of adolescents and young adults (AYAs) in clinical oncology t...
Survival among adolescents and young adults (AYAs) ages 15 to 39 with cancer has not improved to the...